|38.33||+0.1100||+0.29%||Vol 22.62K||1Y Perf -3.30%|
|Apr 16th, 2021 11:00 DELAYED|
|- -%||- -|
|Target Price||46.57||Analyst Rating||Moderate Buy 2.25|
|Potential %||21.21||Finscreener Ranking||★★★★+ 58.48|
|Insiders Trans % 3/6/12 mo.||-/-/27||Value Ranking||★★★★+ 58.99|
|Insiders Value % 3/6/12 mo.||-/-/4||Growth Ranking||★★★ 52.45|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/4||Income Ranking||— -|
|Market Cap||1.54B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||51.65||Earnings Date||4th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th May 2021|
|Estimated EPS Next Report||-0.10|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||144.08K|
|Avg. Monthly Volume||201.65K|
|Avg. Quarterly Volume||208.40K|
Cardiovascular Systems Inc. (NASDAQ: CSII) stock closed at 38.22 per share at the end of the most recent trading day (a 0.76% change compared to the prior day closing price) with a volume of 102.89K shares and market capitalization of 1.54B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 779 people. Cardiovascular Systems Inc. CEO is Scott R. Ward.
The one-year performance of Cardiovascular Systems Inc. stock is -3.3%, while year-to-date (YTD) performance is -12.66%. CSII stock has a five-year performance of 173.39%. Its 52-week range is between 27.7 and 48.28, which gives CSII stock a 52-week price range ratio of 51.65%
Cardiovascular Systems Inc. currently has a PE ratio of -63.70, a price-to-book (PB) ratio of 5.34, a price-to-sale (PS) ratio of 8.83, a price to cashflow ratio of 289.80, a PEG ratio of 2.32, a ROA of -6.81%, a ROC of -8.46% and a ROE of -9.39%. The company’s profit margin is -11.00%, its EBITDA margin is -6.00%, and its revenue ttm is $167.26 Million , which makes it $4.16 revenue per share.
Of the last four earnings reports from Cardiovascular Systems Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Cardiovascular Systems Inc.’s next earnings report date is 04th May 2021.
The consensus rating of Wall Street analysts for Cardiovascular Systems Inc. is Moderate Buy (2.25), with a target price of $46.57, which is +21.21% compared to the current price. The earnings rating for Cardiovascular Systems Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cardiovascular Systems Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cardiovascular Systems Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.47, ATR14 : 1.54, CCI20 : -12.59, Chaikin Money Flow : -0.08, MACD : -1.38, Money Flow Index : 57.68, ROC : 1.06, RSI : 53.61, STOCH (14,3) : 46.09, STOCH RSI : 1.00, UO : 45.01, Williams %R : -53.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cardiovascular Systems Inc. in the last 12-months were: Alexander Rosenstein (Sold 5 377 shares of value $171 745 ), Erik Paulsen (Buy at a value of $13 140), Jeffrey S. Points (Buy at a value of $32 010), Martha Goldberg Aronson (Buy at a value of $193 310), Rhonda J. Robb (Buy at a value of $31 969), Sandra M. Sedo (Sold 3 354 shares of value $107 538 ), Scott R. Ward (Buy at a value of $32 187)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.